![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Shandong Qilu King-phar Pharmaceutical Co., Ltd Pingyin Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Spectinomycin dihydrochloride pentahydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2016-229 - Rev 01
This Chemical Type CEP, issued on May 27, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1152 associated with this CEP further emphasizes